CLOV
Clover Health Investments, Corp.NASDAQHealthcare$1.72+1.18%ClosedMarket Cap: $880.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.13
P/S
0.50
EV/EBITDA
-10.48
DCF Value
$-7.09
FCF Yield
-7.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.5%
Operating Margin
-4.4%
Net Margin
-4.4%
ROE
-25.7%
ROA
-15.8%
ROIC
-25.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $487.7M | 15.2% | $-49.3M | $-49.3M | $-0.10 | — |
| FY 2025 | $1.92B | 18.5% | $-85.5M | $-85.5M | $-0.17 | — |
| Q3 2025 | $496.6M | 14.7% | $-24.4M | $-24.4M | $-0.05 | — |
| Q2 2025 | $477.6M | 20.9% | $-10.6M | $-10.6M | $-0.02 | — |
| Q1 2025 | $462.3M | 23.6% | $-1.3M | $-1.3M | $-0.00 | — |
| Q4 2024 | $337.0M | 27.9% | $-21.4M | $-22.1M | $-0.04 | — |
| FY 2024 | $1.37B | 26.6% | $-45.7M | $-43.0M | $-0.09 | — |
| Q3 2024 | $331.0M | 24.5% | $-8.8M | $-9.2M | $-0.02 | — |
| Q2 2024 | $356.3M | 30.3% | $7.2M | $7.4M | $0.01 | — |
| Q1 2024 | $346.9M | 23.6% | $-22.7M | $-19.2M | $-0.04 | — |
| Q4 2023 | $510.3M | 12.2% | $-65.7M | $-70.5M | $-0.15 | — |
| FY 2023 | $1.26B | 20.3% | $-205.3M | $-213.4M | $-0.45 | — |